A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD - No Study Results Posted

A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD (ICELAND)

This study is ongoing, but not recruiting participants.

Study NCT00378690 Information provided by Astellas Pharma Inc

First Received: September 19, 2006 Last Updated: October 19, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2011
Estimated Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)